Evidence map›Paper›PMID 38586159›Full record

ArticleJournal of the Endocrine Society2024

Low Cortisone as a Novel Predictor of the Low-Renin Phenotype.

Alejandra Tapia-Castillo, Cristian A Carvajal, Jorge A Pérez, Alejandra Sandoval, Fidel Allende, Sandra Solari, Carlos E Fardella

Abstract read
In one paragraph

Article in Journal of the Endocrine Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Alejandra Tapia-CastilloDepartment of Endocrinology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8330077, Chile.ORCID https://orcid.org/0000-0002-6081-1468
Cristian A CarvajalDepartment of Endocrinology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8330077, Chile.ORCID https://orcid.org/0000-0002-0668-412X
Jorge A PérezDepartment of Endocrinology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8330077, Chile.ORCID https://orcid.org/0000-0003-4745-6219
Alejandra SandovalDepartment of Endocrinology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8330077, Chile.
Fidel AllendeDepartment of Clinical Laboratories, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 7820436, Chile.
Sandra SolariDepartment of Clinical Laboratories, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 7820436, Chile.
Carlos E FardellaDepartment of Endocrinology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8330077, Chile.ORCID https://orcid.org/0000-0002-5500-4434

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A large proportion of patients with low-renin hypertension (LRH) correspond to primary aldosteronism (PA). However, some of these subjects have low to normal aldosterone. Since low renin is driven by excessive mineralocorticoids or glucocorticoids acting on mineralocorticoid receptors (MRs), we hypothesize that a low-cortisone condition, associated classically with 11βHSD2 deficiency, is a proxy of chronic MR activation by cortisol, which can also lead to low renin, elevated blood pressure, and renal and vascular alterations. Objective: To evaluate low cortisone as a predictor of low renin activity and its association with parameters of kidney and vascular damage. Methods: A cross-sectional study was carried out in 206 adult subjects. The subjects were classified according to low plasma renin activity (<1 ng/mL × hours) and low cortisone (<25th percentile). Results: Plasma renin activity was associated with aldosterone (r = 0.36; Conclusion: This is the first study showing that low cortisone is a predictor of a low-renin condition. Low cortisone also predicted surrogate markers of vascular and renal damage. Since the aldosterone to renin ratio is used in the screening of PA, low cortisone values should be considered additionally to avoid false positives in the aldosterone-renin ratio calculation.

Indexed as

aldosteronecortisolcortisonelow-renin hypertension

Identifiers

PMID38586159
PMCPMC10998281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.